Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)875-877
Number of pages3
JournalThe Lancet
Volume397
Issue number10277
DOIs
StatePublished - 6 Mar 2021

Cite this